We didn’t just rethink smell testing. We made it matter.
Smell loss is one of the first signs of CRSwNP and one of the last things ENTs pay attention to. It ranks eighth in clinical importance, and the way it’s tested hasn’t changed in over 30 years. At the same time, fragrance is everywhere. It’s emotional, personal, and powerful.
REAWAKEN is a luxury fragrance designed to diagnose. Each note is crafted to reveal a stage of smell loss, transforming a single spray into a fast, sensory screening tool. What starts as a scent becomes a signal—and a reason to act sooner.
Outside the AAO-HNSF Annual Meeting, a sleek fragrance pop-up draws ENTs in with high design and luxury appeal. But one sniff shifts everything: if their patients can’t smell it, disease may already be progressing. Inside, real CRSwNP patients share raw, personal stories that make the science hit harder. Interactive displays tie smell loss to Type 2 inflammation, while Dupixent data shows how quickly it can come back. What begins as luxury launch becomes a moment of clinical urgency.
The pop-up that turns into a wake-up.
TikTok made fragrance culture explode. But for people with CRSwNP scent is more than a trend, it’s a warning sign. That’s why we’re turning “SmellTok” into a clinical wake-up call.
We launch REAWAKEN with real doctors and real patients. Each one sprays the scent on camera. Some react with joy. Others smell nothing. Every video shows what smell loss really means, and why it’s time to take it seriously. If you can’t smell it, your disease may already be progressing.
This is how we make smell matter again.
#SmellReawakens
